Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Daiichi Sankyo
Federal Trade Commission
Farmers Insurance
Argus Health
Colorcon
Fuji
Harvard Business School
McKinsey
Chubb

Generated: February 25, 2018

DrugPatentWatch Database Preview

NALIDIXIC ACID - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for nalidixic acid and what is the scope of nalidixic acid freedom to operate?

Nalidixic acid
is the generic ingredient in two branded drugs marketed by Sanofi Aventis Us, Sun Pharm Industries, and Watson Labs, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for nalidixic acid.
Medical Subject Heading (MeSH) Categories for NALIDIXIC ACID

US Patents and Regulatory Information for NALIDIXIC ACID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us NEGGRAM nalidixic acid TABLET;ORAL 014214-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs NALIDIXIC ACID nalidixic acid TABLET;ORAL 071936-001 Jun 29, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Industries NALIDIXIC ACID nalidixic acid TABLET;ORAL 070270-001 Jun 29, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Industries NALIDIXIC ACID nalidixic acid TABLET;ORAL 070271-001 Jun 29, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us NEGGRAM nalidixic acid TABLET;ORAL 014214-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Industries NALIDIXIC ACID nalidixic acid TABLET;ORAL 070272-001 Jun 29, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs NALIDIXIC ACID nalidixic acid TABLET;ORAL 072061-001 Jun 29, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us NEGGRAM nalidixic acid TABLET;ORAL 014214-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs NALIDIXIC ACID nalidixic acid TABLET;ORAL 071919-001 Jun 29, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us NEGGRAM nalidixic acid SUSPENSION;ORAL 017430-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for NALIDIXIC ACID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us NEGGRAM nalidixic acid SUSPENSION;ORAL 017430-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us NEGGRAM nalidixic acid TABLET;ORAL 014214-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us NEGGRAM nalidixic acid TABLET;ORAL 014214-004 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us NEGGRAM nalidixic acid SUSPENSION;ORAL 017430-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us NEGGRAM nalidixic acid TABLET;ORAL 014214-005 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
UBS
AstraZeneca
Citi
Cantor Fitzgerald
Johnson and Johnson
Colorcon
Merck
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot